Saxo Market Call cover image

Market complacency challenged by latest blitz of Trump administration moves

Saxo Market Call

00:00

Merck's takeover of Revolution Medicines

John Hardy outlines Merck's potential $28–32bn bid for RVMD and strategic drivers around Keytruda.

Play episode from 06:25
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app